Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 250-061-4 | CAS number: 30124-94-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 18 February 1994 to 7 March 1994
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- No Prival modification, 4 strains tested
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- First Addendum to OECD Guidelines for Testing of Chemicals, Section 4, No. 4 71, "Salmonella typhimurium, Reverse Mutation Assay", adopted May 26, 1983
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- EEC Directive 92/69, L 383 A, Annex V, B 14, dated December 29, 1992.
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 2-[[4-[(2-cyano-3-nitrophenyl)azo]-m-tolyl](2-acetoxyethyl)amino]ethyl acetate
- EC Number:
- 250-061-4
- EC Name:
- 2-[[4-[(2-cyano-3-nitrophenyl)azo]-m-tolyl](2-acetoxyethyl)amino]ethyl acetate
- Cas Number:
- 30124-94-8
- Molecular formula:
- C21H21N5O6
- IUPAC Name:
- 2-[[4-[(2-cyano-3-nitrophenyl)azo]-m-tolyl](2-acetoxyethyl)amino]ethyl acetate
- Test material form:
- solid: particulate/powder
Constituent 1
Method
- Target gene:
- Histidine
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- According to the results of this pre-experiment the concentrations applied in the main experiments were chosen. The concentration range covered two logarithmic decades.
The maximum concentration was 5000.0 μg/plate in experiment I and 1000.0 μg/plate in experiment I. The concentration range included two logarithmic decades. In this study six adequately spaced concentrations were tested. Two independent experiments were performed.
As the results of the pre-experiment were in accordance with the criteria described, these data are reported as a part of the main experiment I.
According to the dose selection criteria the test article was tested at the following concentrations:
Exp. I: 33.3; 100.0; 333.3; 1000.0; 2500.0; and 5000.0 μg/plate
Exp. II: 33.3; 66.6; 100.0; 333.3; 666.6; and 1000.0 μg/plate - Vehicle / solvent:
- On the day of experiment, the test article was dissolved in DMF.
The solvent was chosen because of its solubility properties and its relative non-toxicity for the bacteria.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- other: 4-nitro-o-phenylene-diamine (4-NOPD); 2-aminoanthracene (2-AA)
- Details on test system and experimental conditions:
- THE TEST SYSTEM
Characterisation of the Salmonella typhimurium Strains
The strains are derived from s. typhimurium strain LT2 and due to a mutation in the histidine locus are histidine dependent. Additionally due to the "deep rough" (rfa-minus) mutation they possess a faulty lipopolysaccharide envelope which enables substances to penetrate the cell wall more easily. A further mutation causes a reduction in the activity of an excision repair system. The latter alteration includes mutational processes in the nitrate reductase and biotin genes produced in a UV-sensitive area of the gene named "uvrB-minus". In the strains TA 98 and TA 100 the R-factor plasmid pKM 101 carries the ampicillin resistance marker.
In summary, the mutations of the TA strains used in this study can be described as follows:
Salmonella typhimurium
TA 1537: his c 3076; rfa-; uvrB-; frame shift mutations
TA 98: his D 3052; rfa-; uvrB-;R-factor: frame shift mutations
TA 1535: his G 46; rfa-; uvrB-; base-pair substitutions
TA 100: his G 46; rfa-; uvrB-;R-factor: base-pair substitution
Regular checking of the properties of the strains with regard to membrane permeability and ampicillin resistance as well as spontaneous mutation rates is performed in C C R according to Ames et al. In this way it was ensured that the experimental conditions set down by Ames were fulfilled.
The bacterial strains were obtained from Dr. Heinz Trager, Knoll AG, D-67008 Ludwigshafen, F.R.G.
Storage
The strain cultures were stored as stock cultures in ampoules with nutrient broth + 5 % DMSO (MERCK, D-64293 Darmstadt) in liquid nitrogen.
Precultures
From the thawed ampoules of the strains 0.5 ml suspension was transferred to 250 ml Erlenmeyer flasks containing 20 ml nutrient medium. A solution of 20 ml ampicillin was added to the strains
TA 98 and TA 100*. This nutrient medium contains per litre:
8 g Merck Nutrient Broth (MERCK, D-64293 Darmstadt)
5 g NaCl (MERCK, D-64293 Darmstadt)
The bacterial culture was incubated in a shaking water bath for 10 hours at 37 °C.
* in deviation to protocol, updating
Selective Agar
2. 0 % Vogel-Bonner-Glucose-Minimal-Agar was used as selective agar. Each petri dish was filled with 20 ml of this nutrient medium.
Sterilisations were performed at 121° C in an autoclave.
Overlay Agar
The overlay agar contains per litre:
6.0 g Merck Agar Agar*
6.0 g NaCl*
10.5 mg L-histidine x HCl X H20*
12.2 mg biotin*
* (MERCK, D-64293 Darmstadt)
Sterilisations were performed at 121° C in an autoclave.
MAMMALIAN MICROSOMAL FRACTION S9 MIX
The bacteria used in these assays do not possess the enzyme systems which, in mammals, are known to convert promutagens into active DNA damaging metabolites. In order to overcome this major drawback an exogenous metabolic system is added in form of mammalian microsome enzyme activation mixture.
S9 (Preparation by C C R)
The S9 liver microsomal fraction was obtained from the livers of 8 - 12 weeks old male Wistar rats, strain WU (Charles River Wiga GmbH, D-97633 Sulzfeld, F.R.G.; weight approx. 150 - 200 g) which received a single i.p. injection of 500 mg/kg b.w. Aroclor 1254 (Antechnika, D-76275 Ettlingen, F.R.G.) in olive oil 5 days previously.
After cervical dislocation the livers of the animals were removed, washed in 150 mM KCl and homogenised. The homogenate was diluted 1+3 in KCI and centrifuged cold at 9, 000 g for 10 minutes. A stock of the supernatant containing the microsomes was frozen in ampoules of 2, 3 or 5 ml and stored at -80° C. Small numbers of the ampoules are kept at -20° C for only one week before use. The standardisation of the protein content was made using the analysis kit of Bio-Rad Laboratories, D-80939 München:
Bio-Rad protein assay, Catalogue 500 000 6.
The protein concentration in the S9 preparation was 38.2 mg/ml (lot no. 220993).
S9 Mix
Before the experiment an appropriate quantity of S9 supernatant was thawed and mixed with S9 co-factor solution. The amount of S9 supernatant was 15% v/v. The composition of the co-factor solution was concentrated to yield the following concentrations in the S9 mix:
8 mM MgCl2
33 mM KCl
5 mM glucose-6-phosphate
5 mM NADP
in 100 mM ~odium-ortho-phosphate-buffer, pH 7.4.
During the experiment the S9 mix was stored in an ice bath. The S9 mix preparation was performed according to Ames et al.
PRE-EXPERIMENT FOR TOXICITY
To evaluate the toxicity of the test article a pre-experiment was performed with strains TA 98 and TA 100. 8 concentrations were tested for toxicity and mutation induction with each 3 plates. The experimental conditions in this pre-experiment were the same for the experiment I (plate incorporation test).
Toxicity of the test article can be evidenced by a reduction in the number of spontaneous revertants, a clearing of the bacterial background lawn, or by degree of survival of treated cultures.
EXPERIMENTAL PERFORMANCE
For each strain and dose level, including the controls three plates were used-as a minimum.
The following materials were mixed in a test tube and poured onto the selective agar plates:
100 μl
Test solution at each dose level, solvent control, negative control, or reference mutagen solution (positive control),
500 μl
S9 mix (for test with metabolic activation) or S9 mix substitution-buffer (for test without metabolic activation),
100 μl
Bacteria suspension (cf. test system, pre-culture of the strains),
2000 μl
Overlay agar
After solidification the plates were incubated upside down for at least 48 hours at 37° C in the dark.
DATA RECORDING
The colonies were counted using the AUTOCOUNT (Artek Systems Corporation, BIOSYS GmbH, D-61184 Karben; F.R.G.). The counter was connected to an IBM AT compatible PC with printer which printed out the individual values and the means from the plates for each concentration together with standard deviations and (enhancement factors as compared to the spontaneous reversion rates (see tables of results). If precipitation of the test article precluded automatic counting the revertant colonies were counted by hand. - Rationale for test conditions:
- The most widely used assays for detecting gene mutations are those using bacteria. They are relatively simple and rapid to perform, and give reliable data on the ability of an agent to interact with DNA and produce mutations.
In spite of great differences between bacterial and eukaryotic cells with respect to structure and function there is a relationship between mutagenicity in bacteria and carcinogenicity in mammals described in literature.
Reverse mutation assays determine the frequency with which an agent repairs or suppresses the effect of the forward mutation. The genetic target presented to an agent is therefore small, specific and selective. Several bacterial strains, or a single strain with multiple markers are necessary to overcome the effects of mutagen specificity. The reversion of bacteria from growth-dependence on a particular amino acid to growth in the absence of that amino acid (reversion from auxothrophy to prototrophy) is the most widely used marker. The Salmonella typhimurium histidine (his) reversion system measures his- --> his+ reversions. The S. typhimurium strains are constructed to differentiate between base pair (TA 1535, TA 100) and frameshift (TA 1537, TA 98) mutations.
According to the direct plate incorporation or the pre-incubation method the bacteria are exposed to the test article with and without metabolic activation and plated on selective medium. After a suitable period of incubation, revertant colonies are counted.
To establish a dose response effect at least 5 dose levels with adequately spaced intervals are to be tested. The maximum dose level was 5000.0 μg/plate (active ingredient), unless limited by toxicity or solubility of the test article.
To validate the test, reference mutagens are tested in parallel to the test article. - Evaluation criteria:
- The generally accepted conditions for the evaluation of the results are:
- corresponding background growth on both negative controls and test plates
- normal range of spontaneous reversion rates.
A test article is considered positive if either a dose related and reproducible increase in the number of revertants or a significant and reproducible increase for at least one test concentration is induced.
A test article producing neither a dose related and reproducible increase in the number of revertants nor a significant and reproducible positive response at any one of the test points is considered non-mutagenic in this system.
A significant response is described as follows:
A test article is considered mutagenic if in strain TA 100 the number of reversions is at least twice as high and in strains TA 1535, TA 1537 and TA 98 at least three times higher as compared to the spontaneous reversion rate.
Also, a dose-dependent and reproducible increase in the number of revertants is regarded as an indication of possibly existing mutagenic potential of the test article regardless whether the highest dose induced the above described enhancement factors or not. - Statistics:
- Due to international guidelines a statistical evaluation of the results is recommended. However, no evaluated statistical procedure can be recommended for analysis of data from the bacterial assays at this time.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- PRE-EXPERIMENT FOR TOXICITY
To evaluate the toxicity of the test article a pre-study was performed with strains TA 98 and TA 100.
The plates with the test article showed normal background growth up to 5000.0 μg/plate in strain TA 98 and TA 100, respectively.
According to the dose selection criteria, the test article was tested at the following concentrations:
Exp. I: 33.3; 100.0; 333.3; 1000.0; 2500.0; and 5000.0 μg/plate
Exp. II: 33.3; 66.6; 100.0; 333.3; 666.6; and 1000.0 μg/plate
(active ingredient)
Any other information on results incl. tables
PRE-EXPERIMENT FOR TOXICITY
Substance |
Concentration per plate μg |
Revertant per plate |
|||
TA 98 |
TA 100 |
||||
- |
+ |
- |
+ |
||
Negative control |
- |
34 |
41 |
145 |
200 |
Solvent control |
- |
28 |
29 |
147 |
157 |
4-NOPD |
10.0 |
501 |
/ |
/ |
/ |
Sodium azide |
10.0 |
/ |
/ |
751 |
/ |
2-aminoanthracene |
2.5 |
/ |
330 |
/ |
664 |
Test article |
3.3 10.0 33.3 100.0 333.3 1000.0 2500.0 5000.0 |
52 169 443 457 1174 1119 1662 960 |
41 53 70 147 478 860 1176 1463 |
133 237 255 254 244 325 430 417 |
167 180 228 373 383 392 426 497 |
* - without S9 mix; + with S9 mix
/ not performed
SUMMARY OF RESULTS
Without S9 mix
Revertant/plate Mean from three plates |
||||||||
Concentration μg/plate |
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
||||
I |
II |
I |
II |
I |
II |
I |
II |
|
Neg. contr. |
17 |
14 |
9 |
9 |
34 |
38 |
145 |
166 |
Solv. Contr. |
13 |
17 |
8 |
5 |
28 |
29 |
147 |
132 |
33.3 |
16 |
18 |
10 |
8 |
443 |
532 |
255 |
248 |
66.6 |
/ |
10 |
/ |
12 |
/ |
1215 |
/ |
391 |
100.0 |
16 |
21 |
27 |
41 |
457 |
862 |
254 |
341 |
333.3 |
21 |
24 |
48 |
23 |
1174 |
1021 |
244 |
357 |
666.6 |
/ |
10 |
/ |
12 |
/ |
1215 |
/ |
391 |
1000.0 |
10 |
2 |
71 |
0 |
1119 |
1390 |
325 |
456 |
2500.0 |
7 |
/ |
74 |
/ |
1662 |
/ |
430 |
/ |
5000.0 |
0 |
/ |
21 |
/ |
960 |
/ |
417 |
/ |
Positive controls |
||||||||
Sodium azide (10 μg/plate) |
782 |
941 |
|
|
|
|
751 |
889 |
4-nitro-o-pheylene-diamine (10 μg/plate) |
|
|
71 |
91 |
501 |
459 |
|
|
/ = not performed
With S9 mix
Revertant/plate Mean from three plates |
||||||||
Concentration μg/plate |
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
||||
I |
II |
I |
II |
I |
II |
I |
II |
|
Neg. contr. |
16 |
22 |
11 |
13 |
41 |
44 |
200 |
171 |
Solv. Contr. |
19 |
23 |
6 |
15 |
29 |
38 |
157 |
150 |
33.3 |
18 |
23 |
23 |
24 |
70 |
77 |
228 |
226 |
66.6 |
/ |
21 |
/ |
41 |
/ |
115 |
/ |
304 |
100.0 |
23 |
28 |
53 |
64 |
147 |
132 |
373 |
470 |
333.3 |
39 |
32 |
245 |
215 |
478 |
656 |
383 |
663 |
666.6 |
/ |
62 |
/ |
223 |
/ |
1233 |
/ |
558 |
1000.0 |
79 |
95 |
150 |
269 |
860 |
1119 |
392 |
552 |
2500.0 |
88 |
/ |
54 |
/ |
1176 |
/ |
426 |
/ |
5000.0 |
42 |
/ |
11 |
/ |
1463 |
/ |
497 |
/ |
Positive controls |
||||||||
2-aminoanthracene (2.5 μg/plate) |
214 |
160 |
82 |
58 |
330 |
142 |
664 |
643 |
/ = not performed
Applicant's summary and conclusion
- Conclusions:
- In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test article induced gene mutations by base pair changes and frameshifts in the genome of the strains TA 1535, TA 1537, TA 98 and TA 100.
Therefore, the test item is considered to be mutagenic in this Salmonella typhimurium reverse mutation assay. - Executive summary:
This study was ·performed to investigate the potential of FAT 36'036/G to induce gene mutations according to the plate incorporation test using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, and TA 100.
The assay was performed in two independent experiments, both with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test article was tested at the following concentrations:
Exp. I: 33.3; 100.0; 333.3; 1000.0; 2500.0; and 5000.0 μg/plate
Exp. II: 33.3; 66.6; 100.0; 333.3; 666.6; and 1000.0 μg/plate
(active ingredient)
Distinct toxic effects evidenced by a reduction in spontaneous or induced revertant colonies occurred with and without S9 mix in experiment I and II in nearly all strains used.
The plates incubated with the test article showed normal background growth up to 5000.0 μg/plate (experiment I) and 1000.0 μg/plate (experiment II) with and without S9 mix in all strains used.
Reproducible, dose-dependent increases in revertant colony numbers were obtained with the tester strains TA 1535 (with S9 mix), TA 1537 (with and without S9 mix), TA 98 (with and without S9 mix) and TA 100 (with and without S9 mix).
Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies.
CONCLUSION
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test article induced gene mutations by base pair changes and frameshifts in the genome of the strains TA 1535, TA 1537, TA 98 and TA 100.
Therefore, FAT 36'036/G; Terasil Rot 3BL roh feucht (laborgetrocknet) is considered to be mutagenic in this Salmonella typhimurium reverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.